Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?
Background. Aim was to investigate whether the degree of patient activation of patients with type 2 diabetes (T2D) is different between men and women. Furthermore, we investigated which factors are associated with patient activation in men and women. Methods. This cross-sectional study included 1615...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2016/7386532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832555280297099264 |
---|---|
author | Steven H. Hendriks Laura C. Hartog Klaas H. Groenier Angela H. E. M. Maas Kornelis J. J. van Hateren Nanne Kleefstra Henk J. G. Bilo |
author_facet | Steven H. Hendriks Laura C. Hartog Klaas H. Groenier Angela H. E. M. Maas Kornelis J. J. van Hateren Nanne Kleefstra Henk J. G. Bilo |
author_sort | Steven H. Hendriks |
collection | DOAJ |
description | Background. Aim was to investigate whether the degree of patient activation of patients with type 2 diabetes (T2D) is different between men and women. Furthermore, we investigated which factors are associated with patient activation in men and women. Methods. This cross-sectional study included 1615 patients with T2D from general practices. Patient activation was measured with the Patient Activation Measure (PAM) questionnaire. Multivariate linear regression analyses were used to investigate the association between gender and patient activation. Stratified analyses according to gender were performed to investigate which factors are associated with patient activation. Results. No association between gender and PAM score was found after adjustment for all selected confounders (p=0.094). In men, lower age (p=0.001), a higher WHO-5 score (p<0.001), and a lower BMI (p=0.013) were associated with a higher PAM score. In women, a higher WHO-5 score (p<0.017) and the absence of macrovascular complications (p<0.031) were associated with a higher PAM score. Conclusion. There is no difference in the degree of patient activation of men and women with T2D. Age, well-being, and BMI were found to be associated with patient activation in men, whereas well-being and macrovascular complications were found to be associated with patient activation in women. |
format | Article |
id | doaj-art-9aec3f4d2c784f5f8df1754ef17f3ea8 |
institution | Kabale University |
issn | 2314-6745 2314-6753 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Diabetes Research |
spelling | doaj-art-9aec3f4d2c784f5f8df1754ef17f3ea82025-02-03T05:48:39ZengWileyJournal of Diabetes Research2314-67452314-67532016-01-01201610.1155/2016/73865327386532Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?Steven H. Hendriks0Laura C. Hartog1Klaas H. Groenier2Angela H. E. M. Maas3Kornelis J. J. van Hateren4Nanne Kleefstra5Henk J. G. Bilo6Diabetes Centre, Isala, 8000 GK Zwolle, NetherlandsDiabetes Centre, Isala, 8000 GK Zwolle, NetherlandsDepartment of General Practice, University of Groningen and University Medical Center Groningen, 9713 GZ Groningen, NetherlandsDepartment of Cardiology, Radboud University Medical Center, 6525 HP Nijmegen, NetherlandsLangerhans Medical Research Group, 8025 BT Zwolle, NetherlandsLangerhans Medical Research Group, 8025 BT Zwolle, NetherlandsDiabetes Centre, Isala, 8000 GK Zwolle, NetherlandsBackground. Aim was to investigate whether the degree of patient activation of patients with type 2 diabetes (T2D) is different between men and women. Furthermore, we investigated which factors are associated with patient activation in men and women. Methods. This cross-sectional study included 1615 patients with T2D from general practices. Patient activation was measured with the Patient Activation Measure (PAM) questionnaire. Multivariate linear regression analyses were used to investigate the association between gender and patient activation. Stratified analyses according to gender were performed to investigate which factors are associated with patient activation. Results. No association between gender and PAM score was found after adjustment for all selected confounders (p=0.094). In men, lower age (p=0.001), a higher WHO-5 score (p<0.001), and a lower BMI (p=0.013) were associated with a higher PAM score. In women, a higher WHO-5 score (p<0.017) and the absence of macrovascular complications (p<0.031) were associated with a higher PAM score. Conclusion. There is no difference in the degree of patient activation of men and women with T2D. Age, well-being, and BMI were found to be associated with patient activation in men, whereas well-being and macrovascular complications were found to be associated with patient activation in women.http://dx.doi.org/10.1155/2016/7386532 |
spellingShingle | Steven H. Hendriks Laura C. Hartog Klaas H. Groenier Angela H. E. M. Maas Kornelis J. J. van Hateren Nanne Kleefstra Henk J. G. Bilo Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? Journal of Diabetes Research |
title | Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? |
title_full | Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? |
title_fullStr | Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? |
title_full_unstemmed | Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? |
title_short | Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women? |
title_sort | patient activation in type 2 diabetes does it differ between men and women |
url | http://dx.doi.org/10.1155/2016/7386532 |
work_keys_str_mv | AT stevenhhendriks patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT laurachartog patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT klaashgroenier patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT angelahemmaas patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT kornelisjjvanhateren patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT nannekleefstra patientactivationintype2diabetesdoesitdifferbetweenmenandwomen AT henkjgbilo patientactivationintype2diabetesdoesitdifferbetweenmenandwomen |